棕榈酰化
生物
表皮生长因子受体
癌症研究
半胱氨酸
细胞生物学
激酶
受体酪氨酸激酶
表皮生长因子受体抑制剂
信号转导
磷酸化
酪氨酸激酶
受体
生物化学
酶
作者
Kristin B. Runkle,Akriti Kharbanda,Ewa Stypulkowski,Xing-Jun Cao,Wei Wang,Benjamin Aaron Garcia,Eric S. Witze
出处
期刊:Molecular Cell
[Elsevier BV]
日期:2016-05-01
卷期号:62 (3): 385-396
被引量:237
标识
DOI:10.1016/j.molcel.2016.04.003
摘要
Inappropriate activation of the receptor tyrosine kinase EGFR contributes to a variety of human malignancies. Here we show a mechanism to induce vulnerability to an existing first line treatment for EGFR-driven cancers. We find that inhibiting the palmitoyltransferase DHHC20 creates a dependence on EGFR signaling for cancer cell survival. The loss of palmitoylation increases sustained EGFR signal activation and sensitizes cells to EGFR tyrosine kinase inhibition. Our work shows that the reversible modification of EGFR with palmitate "pins" the unstructured C-terminal tail to the plasma membrane, impeding EGFR activation. We identify by mass spectrometry palmitoylated cysteine residues within the C-terminal tail where mutation of the cysteine residues to alanine is sufficient to activate EGFR signaling promoting cell migration and transformation. Our results reveal that the targeting of a peripheral modulator of EGFR signaling, DHHC20, causes a loss of signal regulation and susceptibility to EGFR inhibitor-induced cell death.
科研通智能强力驱动
Strongly Powered by AbleSci AI